Advanced Search

Journal of Traditional Chinese Medicine >

2022 , Vol. 42 >Issue 6: 948 - 955

DOI: https://doi.org/10.19852/j.cnki.jtcm.20220707.001

Research Articles

Yanghe decoction (阳和汤) attenuated pain hypersensitivity induced by michigan cancer foundation-7 injection in rats with bone metastases from breast cancer by inhibiting transient receptor potential ankyrin 1

  • Hui GONG ,
  • Yang LI ,
  • Lei FENG ,
  • Yujie XIAO ,
  • Lizhong HUANG ,
  • Dan MAO ,
  • Hui ZHANG
Expand
  • 1 Department of Medical Oncology, Hunan Academy of Traditional Chinese Medicine Affiliated Hospital, Changsha 410006, China
    2 Department of Medical Oncology,Hunan University of Chinese Medicine, Changsha 410208, China
    3 Department of Integrated Traditional Chinese and Western Medicine, the Second Xiangya Hospital, Central South University, Changsha 410011, Changsha, China
    4 Department of Medical Oncology, Hunan Cancer Hospital, Changsha 410031, China
    5 Department of Medical Oncology, Hainan Hospital of Traditional Chinese Medicine, Haikou 570203, China
ZHANG Hui, Department of Medical Oncology, Hainan Hospital of Traditional Chinese Medicine, Haikou 570203, China. zhanghui20202021@163.com, Telephone: +86-731-85295242
MAO Dan, Department of Integrated Traditional Chinese and Western Medicine, the Second Xiangya Hospital, Central South University, Changsha 410011, China. maodan@csu.edu.cn;

Received date: 2021-09-26

  Accepted date: 2021-12-21

  Online published: 2022-07-07

Supported by

Pathogenesis of “Impassability Leads to Pain” about Bone Metastasis based on Proinflammatory Cytokines Activate TRPA1(2018M632971);Study on the Effect and Mechanism of Yanghe Decoction Regulating cxcl12/cxcr4 Biological Axis against Bone Metastasis of Breast Cancer in Yang Deficiency Syndrome(2020JJ8088);Study on the Mechanism of Bone Loss in Breast Cancer Bone Metastasis by Warm Yang Method from the Pathway of TNF-α/NF-κB/Autophagy(2021JJ30418);Clinical Efficiency of Liushen Pill in Treatment of Bone Cancer Pain and Study on the Analgesic Mechanism of Bone Cancer Pain of Rat Model(ZDYF2021SHFZ225)

Fold

Abstract

OBJECTIVE: To study the effect and underlying mechanisms of Chinese medicine Yanghe decoction (阳和汤) on pain relief in a rat model of bone metastasis of breast cancer induced by michigan cancer foundation-7 (MCF-7).

METHODS: Bone pain was induced in the tibia of rats injected with MCF-7 cells. The Chinese herbal remedy was used to decoct Yanghe decoction for the treatment of bone pain rats. The behavior study was carried out to evaluate the paw mechanical withdraw threshold and thermal withdraw latency. Liquid chromatography-mass spectrometry, Western blotting, quantitative real-time polymerase chain reaction, enzyme-linked immunosorbent assay (ELISA), immunohistochemical (IHC) staining were performed for analysis.

RESULTS: Yanghe decoction could improve the defensive behavior similar to the transient receptor potential ankyrin 1 (TRPA1) inhibitor. In morphology study, Yanghe decoction could attenuate the cellular growth as well as inflammatory infiltration in the metastasis group. Furthermore, Yanghe decoction downregulated the TRPA1 expression on the dorsal root ganglion from the metastatic rats at both transcriptional and protein level. Yanghe decoction alleviated the inflammation in metastatic tissues by hematoxylin-eosin and IHC analysis, and Yanghe decoction also reduced the inflammatory cytokines production in the serum including tumor necrosis factor-α and interleukin-6, interleukin-1 beta by ELISA. As the cytochromec oxidase subunit II/prostaglandin E2 (PGE2) is required for cancer development, Yanghe decoction reduced the expression of PGE2 in the tissue and serum.

CONCLUSION: Taken together, Yanghe decoction protected the rats from breast cancer bone metastasis through TRPA1 signaling mediated neuropathic pain and additional immune modulation in tumor microenvironment.

Key words： bone neoplasms; bone metastasis; Pain; hypersensitivity; TRPA1 cation channel; inflammatory cytokines; Yanghe decoction

Cite this article

Hui GONG , Yang LI , Lei FENG , Yujie XIAO , Lizhong HUANG , Dan MAO , Hui ZHANG . Yanghe decoction (阳和汤) attenuated pain hypersensitivity induced by michigan cancer foundation-7 injection in rats with bone metastases from breast cancer by inhibiting transient receptor potential ankyrin 1[J]. Journal of Traditional Chinese Medicine, 2022 , 42(6) : 948 -955 . DOI: 10.19852/j.cnki.jtcm.20220707.001

References

[1] Ren S, Liu J, Feng Y, et al. Knockdown of circDENND4C inhibits glycolysis, migration and invasion by up-regulating miR-200b/c in breast cancer under hypoxia. J Exp Clin Cancer Res 2019; 38: 388.
[2] Yu Y, Luo W, Yang ZJ, et al. miR-190 suppresses breast cancer metastasis by regulation of TGF-beta-induced epithelial-mesenchymal transition. Mol Cancer 2018; 17: 70.
[3] Ungard RG, Linher-Melville K, Nashed MG, Sharma M, Wen J, Singh G. xCT knockdown in human breast cancer cells delays onset of cancer-induced bone pain. Mol Pain 2019; 15: 1744806918822185.
[4] Yuan X, Qian N, Ling S, et al. Breast cancer exosomes contribute to pre-metastatic niche formation and promote bone metastasis of tumor cells. Theranostics 2021; 11: 1429-45.
[5] Salvador F, Llorente A, Gomis RR. From latency to overt bone metastasis in breast cancer: potential for treatment and prevention. J Pathol 2019; 249: 6-18.
[6] Croset M, Pantano F, Kan CWS, et al. miRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-asociated genes. Cancer Res 2018; 78: 5259-73.
[7] Wang S, Lin H, Cong W. Chinese medicines improve perimenopausal symptoms induced by surgery, chemoradiotherapy, or endocrine treatment for breast cancer. Front Pharmacol 2019; 10: 174.
[8] Wang S, Long S, Wu W. Application of Traditional Chinese Medicines as personalized therapy in human cancers. Am J Chin Med 2018; 46: 953-70.
[9] Guan H, Li K, Wang X, et al. Identification of metabolites of the cardioprotective alkaloid dehydrocorydaline in rat plasma and bile by liquid chromatography coupled with triple quadrupole linear ion trap mass spectrometry. Molecules 2017; 22: 1686.
[10] Du GH, Yuan TY, Du LD, Zhang YX. The potential of Traditional Chinese Medicine in the treatment and modulation of pain. In: Barrett JE, ed. Advances in Pharmacology: Academic Press, 2016: 325-61.
[11] Han CS, Chou PH, Lu CC, Lu LH, Yang TH, Jen MF. The role of central 5-hydroxytryptamine in acupuncture analgesia. Sci Sin 1979; 22: 91-104.
[12] Qi Y, Li S, Pi Z, et al. Chemical profiling of Wu-tou decoction by UPLC-Q-TOF-MS. Talanta 2014; 118: 21-9.
[13] Liu XF, Li JW, Chen HZ, et al. Yanghe Huayan decoction inhibits the capability of trans-endothelium and angiogenesis of HER2+ breast cancer via pAkt signaling. Biosci Rep 2019; 39: BSR20181260.
[14] Mao D, Feng L, Gong H. The antitumor and immunomodulatory effect of Yanghe decoction in breast cancer is related to the modulation of the JAK/STAT signaling pathway. Evid Based Complement Alternat Med 2018; 2018: 8460526.
[15] Zhao D, Han DF, Wang SS, Lv B, Wang X, Roles of tumor necrosis factor-alpha and interleukin-6 in regulating bone cancer pain via TRPA1 signal pathway and beneficial effects of inhibition of neuro-inflammation and TRPA1. Mol Pain 2019; 15: 1744806919857981.
[16] de Almeida AS, Pereira GC, Brum EDS, et al. Role of TRPA1 expressed in bone tissue and the antinociceptive effect of the TRPA1 antagonist repeated administration in a breast cancer pain model. Life Sci 2021; 276: 119469.
[17] Eid SR, Crown ED, Moore EL, et al. HC-030031, a TRPA1 selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivity. Mol Pain 2008; 4: 48.
[18] Lizhong H, Ya X, Daan W. Experimental study on Yanghe decoction in inhibiting tumor growth and inducing interferon in S180A bearing mice. Zhong Guo Zhong Yi Yao Xin Xi Za Zhi 2003; 5.
[19] Wang Y, Xiao X. Clinical efficacy of modified Yanghe decoction in ankylosing spondylitis: a randomized controlled trial. Med Sci Monit 2018; 24: 2912-8.
[20] Pan Z, Wang Z, Yang H, Zhang F, Reinach PS. TRPV1 activation is required for hypertonicity-stimulated inflammatory cytokine release in human corneal epithelial cells. Invest Ophthalmol Vis Sci 2011; 52: 485-93.
[21] Nilius B, Owsianik G, Voets T, Peters JA. Transient receptor potential cation channels in disease. Physiol Rev 2007; 87: 165-217.
[22] Nilius B, Owsianik G. The transient receptor potential family of ion channels. Genome Biol 2011; 12: 218.
[23] McNamara CR, Mandel-Brehm J, Bautista DM, et al. TRPA1 mediates formalin-induced pain. Proc Natl Acad Sci U S A 2007; 104: 13525-30.
[24] Bautista DM, Jordt SE, Nikai T, et al. TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 2006; 124: 1269-82.
[25] Dai Y, Wang S, Tominaga M, et al. Sensitization of TRPA1 by PAR2 contributes to the sensation of inflammatory pain. J Clin Invest 2007; 117: 1979-87.
[26] Meseguer V, Alpizar YA, Luis E, et al. TRPA1 channels mediate acute neurogenic inflammation and pain produced by bacterial endotoxins. Nat Commun 2014; 5: 3125.
[27] Schwartz ES, La JH, Scheff NN, Davis BM, Albers KM, Gebhart GF. TRPV1 and TRPA1 antagonists prevent the transition of acute to chronic inflammation and pain in chronic pancreatitis. J Neurosci 2013; 33: 5603-11.
[28] Schaefer EA, Stohr S, Meister M, Aigner A, Gudermann T, Buech TR. Stimulation of the chemosensory TRPA1 cation channel by volatile toxic substances promotes cell survival of small cell lung cancer cells. Biochem Pharmacol 2013; 85: 426-38.
[29] Zhang Y. Allyl isothiocyanate as a cancer chemopreventive phytochemical. Mol Nutr Food Res 2010; 54: 127-35.
Options
Outlines

/

〈 〉